Skip to main content
Banka BioLoo Limited logo

Banka BioLoo Limited — Investor Relations & Filings

Ticker · BANKA ISIN · INE862Y01015 LEI · 9845007A5B684495YW41 National Stock Exchange of India Water supply; sewerage, waste management and remediation activities
Open in API
Filings indexed 463 across all filing types
Latest filing 2025-08-05 Capital/Financing Update
Country IN India
Listing National Stock Exchange of India BANKA

About Banka BioLoo Limited

https://www.bankabio.com

Banka BioLoo Limited specializes in providing sustainable sanitation solutions through the implementation of bio-digester technology. The company focuses on the design, manufacturing, and installation of bio-toilets and bio-tanks that utilize anaerobic digestion to treat human waste. This technology, originally developed by the Defence Research and Development Organisation (DRDO), converts waste into water and biogas, ensuring zero-waste discharge and environmental protection. The company serves a diverse range of sectors, including public infrastructure, railways, construction sites, and rural communities. Its service offerings extend to the operation and maintenance of sanitation facilities, as well as large-scale waste management projects. By prioritizing water conservation and hygiene, the company addresses critical sanitation challenges while promoting ecological sustainability.

Recent filings

Filing Released Lang Actions
Updates
Capital/Financing Update Classification · 95% confidence The document is a formal communication from Banka BioLoo Limited to the National Stock Exchange of India regarding the listing and trading approval of 9,900 equity shares allotted under the Employee Stock Option Plan (ESOP). It includes details about the allotment, approval date, and effective trading date. The document also contains the approval letter from NSE confirming the listing and admission to dealings of these shares. There are no financial statements, management discussion, or detailed financial data present. The document is an announcement about a capital market event related to share issuance and listing approval, specifically concerning further issue of shares under ESOP. This fits the category of Capital/Financing Update (CAP) as it relates to company fundraising and capital structure changes through share allotment and listing approval.
2025-08-05 English
Updates
Capital/Financing Update Classification · 95% confidence The document is a formal communication from Banka BioLoo Limited to the National Stock Exchange of India regarding the listing and trading approval of 9,900 equity shares allotted under the Employee Stock Option Plan (ESOP). It includes the approval letter from NSE confirming the listing and admission to dealings of these shares. The content focuses on the announcement of a capital market event related to share issuance and listing approval, without any financial statements or detailed financial analysis. The document length is 3,326 characters, which is relatively short and primarily serves as an announcement of a capital change event. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as share allotments under ESOP and their listing approvals.
2025-08-01 English
Board Meeting — Financial Results/Other business matters
Regulatory Filings Classification · 95% confidence The document is a letter from Banka BioLoo Limited addressed to the National Stock Exchange of India, informing about a scheduled Board Meeting on 8 August 2025 to consider and approve unaudited standalone and consolidated financial results for the quarter ended 30 June 2025. It references Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) and mentions the trading window closure related to insider trading regulations. The document does not contain the financial results themselves but is an announcement of the upcoming board meeting and the intention to approve the quarterly financial results. The document length is 2405 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this is a Regulatory Filing (RNS) as it is a general regulatory announcement about the board meeting and financial results approval, not the financial report itself or a detailed interim report.
2025-07-31 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2025-07-07 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2025-06-25 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to the stock exchange notifying the closure of the trading window for insiders ahead of the announcement of unaudited quarterly financial results. It references compliance with insider trading regulations and states the trading window will be closed from July 1, 2025, until 48 hours after the declaration of the unaudited financial results for the quarter ending June 30, 2025. There is no actual financial data or results presented in this document, nor is it a report or transcript. It is an announcement related to trading restrictions prior to financial results disclosure. The document length is short (2153 characters) and it serves as a regulatory notification. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance and regulatory announcements that do not fit other categories.
2025-06-25 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.